Skip to Main Content
OUTSOURCE EVERYTHING BUT THE GENIUS™

Welcome, Guest.

Go to Main Navigation

Industry Trends

Showing 1 - 10 of 53 posts
November 18

It’s now well known that biopharmaceutical companies are increasingly turning to third-party suppliers to support their research and development...

November 16

Meaghan Loy, Category Director of In Vivo Services at Scientist.com and member of the North American 3Rs Collaborative Board of Directors...

October 29

The field of preclinical oncology research is being hit by a new wave of innovation, specifically innovation in disease model sourcing for drug...

October 7

Biotechnology companies aim to develop products and technologies that can solve the many health-related problems that plague our world today. The...

September 10

New advancements in technology and ever-evolving channels of communication are making the world a smaller, more connected place. One click of a...

March 22

We are excited to introduce our newly expanded category Value, Evidence and Access and the accompanying rebranded Value, Evidence and Access...

February 25

How does AW or the 3Rs impact your current role? Jessie: Animal welfare and the 3Rs impact my work at AWIC daily. The main focus and mission of...

Jun 21, 2020

As businesses begin to reopen, including laboratories, researchers should expect operations to look slightly different. Based on conversations...

Jun 19, 2020

Over the past weeks, Scientist.com has been working hard to listen, learn and implement short-term and long-term changes regarding diversity within...

Feb 26, 2020

Firstly, I’d like to explain to our audience what Austrade does before sharing how beneficial it can be for global biotechs looking to benefit from...